Home > Cashflow Statement > BALAXI PHARMACEUTICALS

BALAXI PHARMACEUTICALS
Cash Flow from Financing Activities

    Back to Cashflow Statement
BALAXI PHARMACEUTICALS is part of below Screeners ↓
Top Undervalued Small Cap Stocks
AD     Remove this Ad

BALAXI PHARMACEUTICALS Last 5 Year Cash Flow from Financing Activities History

[Consolidated]

Mar2025Mar2024Mar2023Mar2022Mar2021
Cash Flow from Financing Activities ₹34 Cr₹30 Cr₹26 Cr₹-0.16 Cr₹3.65 Cr

What is the latest Cash Flow from Financing Activities ratio of BALAXI PHARMACEUTICALS ?

The latest Cash Flow from Financing Activities ratio of BALAXI PHARMACEUTICALS is ₹34 Cr based on Mar2025 Consolidated results.
Year Cash Flow from Financing Activities
Mar2025₹34 Cr
Mar2024₹30 Cr
Mar2023₹26 Cr
Mar2022₹-0.16 Cr
Mar2021₹3.65 Cr

How is Cash Flow from Financing Activities of BALAXI PHARMACEUTICALS Trending?

Years Cash Flow from Financing Activities % Change
Mar2025 ₹34 Cr
11.97
Mar2024 ₹30 Cr
18.58
Mar2023 ₹26 Cr
Positive
Mar2022 ₹-0.16 Cr
Negative
Mar2021 ₹3.65 Cr -

Compare Cash Flow from Financing Activities of peers of BALAXI PHARMACEUTICALS

Peers & Returns Market Capitalization 1 Week 1 Month 1 Year
BALAXI PHARMACEUTICALS ₹134.6 Cr 0.9% -8.9% -65.5% Stock Analytics
ADANI ENTERPRISES ₹261,044.0 Cr 8.4% -8.8% -10.2% Stock Analytics
REDINGTON ₹21,240.8 Cr 8.4% 1.2% 17.9% Stock Analytics
MMTC ₹9,763.5 Cr 1.9% -3.6% -0.3% Stock Analytics
HONASA CONSUMER ₹8,993.2 Cr 1.5% -5.1% 10.1% Stock Analytics
LLOYDS ENTERPRISES ₹8,878.4 Cr 10.1% -3.3% 7.4% Stock Analytics


BALAXI PHARMACEUTICALS Share Price vs Sensex

Share Price Returns(%) 1 Week 1 Month 1 Year
BALAXI PHARMACEUTICALS

0.9%

-8.9%

-65.5%

SENSEX

-0.1%

-2.9%

7.5%


You may also like the below Video Courses